Unreliable Extended-Spectrum β-Lactamase Detection in the Presence of Plasmid-Mediated AmpC in Escherichia coli Clinical Isolates

被引:59
|
作者
Robberts, F. J. L. [1 ]
Kohner, P. C. [1 ]
Patel, R. [1 ,2 ]
机构
[1] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
关键词
KLEBSIELLA-PNEUMONIAE; SURVEILLANCE PROGRAM; PROTEUS-MIRABILIS; PREVALENCE; IDENTIFICATION; HOSPITALS; AMERICA; KOREA;
D O I
10.1128/JCM.01687-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The emergence of extended-spectrum beta-lactamase (ESBL) and plasmid-mediated AmpC (pAmpC) enzymes in Escherichia coli raises concern regarding accurate laboratory detection and interpretation of susceptibility testing results. Twenty-six cefpodoxime ESBL screen-positive, cefoxitin-resistant E. coli clinical isolates were subjected to clavulanate ESBL confirmatory testing employing disk augmentation, Etest, and the BD Phoenix NMC/ID-132 panel. Phenotypic pAmpC production was assessed by boronic acid disk augmentation. ESBL and pAmpC genes were detected by gene amplification and sequencing. ESBL genes (SHV and/or CTX-M-type genes) were detected in only 7/26 ESBL screen-positive isolates. Of 23 aminophenylboronic acid screen-positive isolates, pAmpC genes were detected in 20 (CMY-2 or FOX-5 genes). High incidences of false-positive ESBL confirmatory results were observed for both clavulanate disk augmentation (9/19) and BD Phoenix (5/19). All were associated with the presence of pAmpC genes with or without TEM-1. Etest performed poorly, as the majority of interpretations were nondeterminable. In addition, false-negative ESBL confirmatory results were observed in isolates possessing concomitant ESBL and pAmpC genes for Etest (four of five), BD Phoenix (three of five), and disk augmentation (one of five). The results indicate poor performance of currently employed ESBL confirmatory methods in the setting of concomitant pAmpC. Some isolates with pAmpC and ESBL genes fell within the susceptible category to extended-spectrum cephalosporins, raising concern over currently employed breakpoints.
引用
收藏
页码:358 / 361
页数:4
相关论文
共 50 条
  • [21] Risk factors for faecal colonisation with Escherichia coli producing extended-spectrum and plasmid-mediated AmpC β-lactamases in dogs
    Belas, A.
    Salazar, A. S.
    da Gama, L. T.
    Couto, N.
    Pomba, C.
    VETERINARY RECORD, 2014, 175 (08) : 202 - +
  • [22] In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae
    Matsumura, Yasufumi
    Yamamoto, Masaki
    Nagao, Miki
    Tanaka, Michio
    Takakura, Shunji
    Ichiyama, Satoshi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 84 (04) : 322 - 327
  • [23] Extended-Spectrum B-Lactamase and Plasmid-Mediated AMPC Genes in Swine and Ground Pork
    Sabia, Carla
    Stefani, Sara
    Messi, Patrizia
    de Niederhaeusern, Simona
    Bondi, Moreno
    Condo, Carla
    Iseppi, Ramona
    Anacarso, Immacolata
    JOURNAL OF FOOD SAFETY, 2017, 37 (01)
  • [24] Association of farm-related factors with characteristics profiles of extended-spectrum β-lactamase-/plasmid-mediated AmpC β-lactamase-producing Escherichia coli isolates from German livestock farms
    Hille, Katja
    Felski, Mayala
    Ruddat, Inga
    Woydt, Johanna
    Schmid, Annette
    Friese, Anika
    Fischer, Jennie
    Sharp, Hannah
    Valentin, Lars
    Michael, Geovana Brenner
    Hoermansdorfer, Stefan
    Messelhaeusser, Ute
    Seibt, Uwe
    Honscha, Walther
    Guerra, Beatriz
    Schwarz, Stefan
    Roesler, Uwe
    Kaesbohrer, Annemarie
    Kreienbrock, Lothar
    VETERINARY MICROBIOLOGY, 2018, 223 : 93 - 99
  • [25] Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases
    Jones, G. Ll.
    Warren, R. E.
    Skidmore, S. J.
    Davies, V. A.
    Gibreel, T.
    Upton, M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1245 - 1251
  • [26] Detection of multidrug resistance and extended-spectrum/plasmid-mediated AmpC beta-lactamase genes in Enterobacteriaceae isolates from diseased cats in Italy
    Lo Piccolo, Francesco
    Belas, Adriana
    Foti, Maria
    Fisichella, Vittorio
    Marques, Catia
    Pomba, Constanca
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2020, 22 (07) : 613 - 622
  • [27] Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
    Pérez-Pérez, FJ
    Hanson, ND
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2153 - 2162
  • [28] Effect of challenge dose of plasmid-mediated extended-spectrum β-lactamase and AmpC β-lactamase producing Escherichia coli on time-until-colonization and level of excretion in young broilers
    Dame-Korevaar, Anita
    Fischer, Egil A. J.
    van der Goot, Jeanet
    Velkers, Francisca
    van den Broek, Jan
    Veldman, Kees
    Ceccarelli, Daniela
    Mevius, Dik
    Stegeman, Arjan
    VETERINARY MICROBIOLOGY, 2019, 239
  • [29] Broad resistance due to plasmid-mediated AmpC β-lactamases in clinical isolates of Escherichia coli
    Odeh, R
    Kelkar, S
    Hujer, AM
    Bonomo, RA
    Schreckenberger, PC
    Quinn, JP
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) : 140 - 145
  • [30] Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E.coli bacteraemia
    Matsumura, Y.
    Nagao, M.
    Iguchi, M.
    Yagi, T.
    Komori, T.
    Fujita, N.
    Yamamoto, M.
    Matsushima, A.
    Takakura, S.
    Ichiyama, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (02) : 161 - 168